Would you get your hip replacement performed in India when you go to visit your 
relatives?
  =================================================
  The Rise of Medical Tourism          Q&A with:  Tarun Khanna    Published:  
December 17, 2007    Author:  Martha Lagace
        Executive Summary:  Medical tourism—traveling far and wide for health 
care that is often better and certainly cheaper than at home—appeals to 
patients with complaints ranging from heart ailments to knee pain. Why is India 
leading in the globalization of medical services? Q&A with Harvard Business 
School's Tarun Khanna. Key concepts include:
    
   Medical tourism is a new term but not a new idea. Patients have long 
traveled in search of better care. Today, constraints and long waiting lists at 
home, as well as the ease of global travel, make medical tourism more 
appealing.   
   Superior medical schools, a low cost of living, family preferences, and the 
barriers to foreign accreditation mean that Indian doctors may prefer to work 
in India rather than elsewhere.   
   The medical services industry is evolving quickly. Khanna expects to see 
dynamics in China similar to those in India and in other parts of Southeast 
Asia. 


    
  Tarun Khanna is the Jorge Paulo Lemann Professor of Business Administration 
at Harvard Business School.
    
   More Working Knowledge from Tarun Khanna   
   Tarun Khanna - Faculty Research Page 

  About Faculty in this Article:  
  Felix Oberholzer-Gee is the Andreas Andresen Associate Professor of Business 
Administration at Harvard Business School.
   
    What used to be rare is now commonplace: traveling abroad to receive 
medical treatment, and to a developing country at that. 
  So-called medical tourism is on the rise for everything from cardiac care to 
plastic surgery to hip and knee replacements. As a recent Harvard Business 
School case study describes, the globalization of health care also provides a 
fascinating angle on globalization generally and is of great interest to 
corporate strategists.
  "Apollo Hospitals—First-World Health Care at Emerging-Market Prices" explores 
how Dr. Prathap C. Reddy, a cardiologist, opened India's first for-profit 
hospital in the southern city of Chennai in 1983. Today the Apollo Hospitals 
Group manages more than 30 hospitals and treats patients from many different 
countries, according to the case. Tarun Khanna, a Harvard Business School 
professor specializing in global strategy, coauthored the case with professor 
Felix Oberholzer-Gee and Carin-Isabel Knoop, executive director of the HBS 
Global Research Group. 
  The medical services industry hasn't been global historically but is becoming 
so now, says Khanna. There are several reasons that globalization can manifest 
itself in this industry: 
    
   Patients with resources can easily go where care is provided. "Historically 
doctors moved from Africa and India to London and New York to provide care. Now 
we are basically flipping it around and saying, 'Why don't the patients move? 
It's not as difficult as it used to be.' "   
   High quality care, state-of-the-art facilities, and skilled doctors are 
available in many parts of the world, including in developing countries.   
   Auxiliary health-care providers such as nurses go where care is needed. 
Filipino nurses provide an example, perhaps. 
  "From a strategic point of view you can move the output or the input," 
explains Khanna. "Applying this idea to human health care sounds a bit crude, 
but the output is the patient, the input is the doctor. We used to move the 
input around, and make doctors go to new locations outside their country of 
origin. But in many instances it might be more efficient to move the patients 
to where the doctors are as long as we are not compromising the health care of 
the patients." 
  Khanna recently sat down with HBS Working Knowledge to discuss the 
globalization of health care in the context of India and Apollo Hospitals.
  Q: What led you to research and write this case?
  A: I came across the company during some of my travels in South India. It was 
so unusual to find "first-world health care at emerging-market prices" as the 
case says. Often better care—by which I mean technologically first-rate care 
with far greater "customer service" and accessibility—is available in parts of 
India than in my neighborhood in Boston. 
  Felix Oberholzer-Gee, Carin-Isabel Knoop, and I decided to write the case 
just because health care is such a primal thing—it arouses a lot of emotions 
and insecurities. After all, it's one's life and health that one is dealing 
with. And the prospect of entrusting health care to a developing country had a 
pedagogical "shock value," too. 
  "A lot of entrusting medical care to different locations is about a 
psychological fear of the unknown."  For a long time I've been interested in 
studying world-class companies in developing countries. For me and my colleague 
Krishna Palepu, India has served as an intellectual laboratory. So I've always 
been anecdotally aware of the possibility that people could benefit from 
India's soft assets, so to speak. In this case that means skilled health-care 
professionals—doctors, nurses, technicians, etc. The fact that the cost of 
living is so much lower in India means that the same service is possible at a 
fraction of the price elsewhere. For most routine issues, as well as invasive 
procedures that are routine, I see no reason why more people would not go to 
India. 
  Q: The term "medical tourism" is fairly new, but how new is the phenomenon of 
going overseas for medical treatment?
  A: When I was a college student in the United States I discovered that dental 
care was very expensive. Even back then, many of my international classmates 
essentially engaged in medical tourism—they would simply bundle up the care 
they needed, make a trip to their country of origin, and take care of it. India 
was certainly one of those countries I was aware of due to my own personal 
background. 
  We didn't have a term for medical tourism, but in a sense it was all around 
us. It took a set of entrepreneurs to begin to make it happen. By the late 
1990s, when I was teaching courses in global strategy, some of my Thai, 
Malaysian, and Singaporean students were perfectly aware of the term, because 
these countries of Southeast Asia already had very good tertiary-care hospitals.
  Medical tourism usually refers to the idea of middle-class or wealthy 
individuals going abroad in search of effective, low-cost treatment. But there 
is another dimension of medical tourism that is not called medical tourism. 
Narayana Hrudayalaya, a heart hospital in India [see article], treats indigent 
people from neighboring countries—Pakistan, Bangladesh, Burma—who suffer from 
heart disease and can't afford surgery. Treatment for them is free. The 
hospital is able to provide it because surgical methods are efficient enough 
that pro bono care doesn't hurt the bottom line. 
  Q: Why is India gaining prominence for medical tourism?
  A: India is encouragingly less "scary" now. I think a lot of entrusting 
medical care to different locations is about a psychological fear of the 
unknown. An important strategic challenge for developing-country hospitals is 
to reduce the psychological fear. 
  In addition, India is rising because there's just a ton of very well-trained 
doctors just like there is a ton of well-trained engineers. Over the decades, 
many engineers have relocated to Silicon Valley, but for doctors it remains the 
case that barriers to entering the U.S. medical profession are still large. 
  In India, the same depth of pool of engineering and mathematical talent for 
software, offshoring, and outsourcing is there for medicine, too. In the 1950s 
and '60s, the Indian government invested a lot in tertiary education. By now 
there is at least a small handful of medical institutes that are really 
first-rate, and the doctors they produce are extremely well trained. 
  When my colleagues and I began to research this case, some other countries 
had already stolen a march on India—Singapore, and Malaysia in particular, and 
areas of the Middle East—yet there was still a lot of room for growth. India 
has had a unique competitive advantage as a result of this deeper pool of 
technical knowledge and the fact that it is simply a large country and has more 
people. 
  I would expect to see dynamics in China similar to what is happening in other 
parts of Southeast Asia. China frequently makes the news for stem cell 
therapies that are not allowed in the West. So while I think India has some 
unique features it is not strictly unique. 
  Q: What are the recruiting challenges for staffing these hospitals with 
doctors? 
  A: In the case, Dr. Prathap C. Reddy, the founder and chairman of Apollo 
Hospitals, says he spent a lot of time studying specialists almost like an 
executive search firm would, to identify their pleasure points and pain points 
in terms of building a successful practice in the West and potentially in 
India. He wanted to understand not just medical training and specialties but 
also family circumstances, since it is always a family decision to relocate. 
  In the past, Indian doctors left India so they could multiply their incomes. 
But now we're seeing the reversal of that. India is booming so why leave, and 
by the way, patients can go there. 
  As the case describes, accreditation is a pretty huge barrier for doctors 
going abroad. Just as Dr. Reddy had to spend time convincing the Indian 
government that the idea of medical tourism was a good use of national 
resources, when we wrote the case he was in the process of convincing various 
countries that similar development made sense. So it's a tricky public policy 
issue. 
  Q: How does growth in private hospitals affect public health care in India? 
  A: There is an assumption in the view often expressed in the media in India 
and Europe, for instance, that when private hospitals in India provide care to 
heart patients from England, the hospitals are somehow taking care away from 
poor people in India. The assumption seems to be that if medical tourism was 
banned, the doctors in question who were catering to wealthy patients would 
suddenly, as a practical matter, move to a village. It takes a different set of 
individuals, a different set of infrastructure circumstances to create that 
scenario. We need good scholarship to verify the idea that there is a potential 
substitution between caring for sick people from England and providing 
medication for malaria in an Indian village. I'm not aware of such analysis yet.
  My guess is that the bulk of India's problem is primary health, and has 
nothing to do with tertiary care. And the primary health problem is not going 
to be addressed by a private hospital for the most part anyway. These are 
almost different industries. If someone analyzes the landscape and discovers 
that there is substitution between care, then there is a real public policy 
issue that needs to be debated. 
  Q: How are marketing strategies evolving?
  A: My observations are that medical tourism is promoted much more heavily in 
the United Kingdom than in the United States. Public interest in Britain is in 
the context of the National Health Service and its constraints. Initially the 
rules required that patients be treated only in the United Kingdom. I believe 
there has been a gradual relaxation in these rules, so that some care can be 
provided within some EU countries. I know that various Indian hospitals are 
continually attempting to get accredited to perform certain procedures.
  What is striking is that in London medical tourism makes the front page of 
newspapers. People ranging from generals in the British Army to politicians to 
blue-collar workers are quoted, all saying, in effect, "I had a great time, and 
now I'm well." The most common treatments seem to be for cardiovascular issues, 
bone-related issues such as hip replacements, and general age-related issues. 
Most of these articles depict people going to India, but they almost never 
profile an Indian going to India. They profile a wide spectrum of citizens, not 
just British citizens of Indian or Asian origin. 
  Q: For-profit hospitals around the world have been associating with 
well-regarded U.S. medical schools and clinics. How can Apollo Hospitals 
differentiate itself from growing competition? 
  A: What is happening now is the normal evolution of an industry, and these 
hospital companies are all trying to figure out what their angle will be.
  I certainly don't think affiliating with a medical school or clinic in the 
West is a panacea. We will see solutions emerge that have nothing to do with 
the West and that specialize in particular kinds of care where the West may not 
even have much competence: tropical diseases in Southeast Asia and Africa, for 
instance. On the other hand, you might see very interesting links between 
particular companies, research institutes, and hospitals in different parts of 
the world—in the Middle East, Europe, the United States. My guess is that 3 or 
4 prominent hospital companies will survive because the demand is so huge. 
  At the end of the day we all ought to celebrate the development of these 
hospitals, because a lot of people who would have to wait in pain for 8 months 
for a hip replacement can get it tomorrow, at much lower expense. People with 
excruciating dental pain can get it fixed, cost effectively, much quicker. And 
patients who need a kidney transplant and have to be on dialysis can get 
attention sooner. As always there are challenges, but from humanity's 
standpoint we ought to celebrate. 


_______________________________________________
assam mailing list
assam@assamnet.org
http://assamnet.org/mailman/listinfo/assam_assamnet.org

Reply via email to